Stockholders re-elect all five directors and approve 1.52M share increase to incentive plan at 2021 annual meeting

Petros Pharmaceuticals, Inc.

All five director nominees (Shulman, Silverman, Bernstein, Bradley, Walker) re-elected with >99% votes cast in favor.
Second Amendment to 2020 Omnibus Incentive Plan approved (5.86M for, 85K against), increasing shares reserved to 2.6M.
EisnerAmper LLP ratified as independent auditor for FY2021 with 9.18M votes for, 36.8K against.
Advisory say-on-pay passed with 5.89M for (98.9% of votes cast); shareholders chose 1-year frequency for future votes.
Voter turnout: 9.23M of total voting power; broker non-votes of ~3.26M on most proposals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.